Most discussions around biologics manufacturing focus on processes, technologies, and outcomes. But what does the day-to-day reality of an MSAT team actually look like?
Manufacturing Science & Technology (MSAT) teams act as vital bridge between R&D and commercial production. When biological processes scale up, unexpected variables - like large-scale protein fragmentation can delay commercial readiness by months and cost significant financial losses.
By anticipating these scale-up challenges, investigating deviations, and optimizing manufacturing data, effective MSAT teams do more than ensuring compliance; they drive revenue. MSAT teams accelerate commercialization timelines by about 15% to 25%, directly translating to higher sales and rapid market entry.
Join us for a candid coffee chat with Puneeth Samani, as we explore how MSAT teams work in practice and discuss the challenges, decisions, and trade-offs that define modern manufacturing operations.
Most discussions around biologics manufacturing focus on processes, technologies, and outcomes. But what does the day-to-day reality of an MSAT team actually look like?
Manufacturing Science & Technology (MSAT) teams act as vital bridge between R&D and commercial production. When biological processes scale up, unexpected variables - like large-scale protein fragmentation can delay commercial readiness by months and cost significant financial losses.
By anticipating these scale-up challenges, investigating deviations, and optimizing manufacturing data, effective MSAT teams do more than ensuring compliance; they drive revenue. MSAT teams accelerate commercialization timelines by about 15% to 25%, directly translating to higher sales and rapid market entry.
Join us for a candid coffee chat with Puneeth Samani, as we explore how MSAT teams work in practice and discuss the challenges, decisions, and trade-offs that define modern manufacturing operations.
Scaling clinico-genomic data integration: Large pharmaceutical organizations working with external data providers used Polly to build interoperable clinico-genomic data products 6x faster.
Although purchased datasets are often labeled as "clean," they still lack interoperability—Polly's pipelines bridge this gap with robust integration and harmonization.
Information Retrieval: Drug safety monitoring teams used Polly's Knowledge Graph powered co-scientist to conversationally retrieve the right cohorts & assess drug response—cutting discovery time by 70%.
%201.svg){kind=icon}
.png)
.png)
.png)
.png)
If you’re working with complex biological data, you may be asking:
Can generative AI truly assist in scientific reasoning, not just data analysis?
What does it mean for hypothesis generation, literature review, or even designing experiments?
Could this accelerate—not replace—my discovery pipeline?
Whether you're skeptical, curious, or already experimenting with AI in your lab—this is a session designed to ground your understanding in evidence, not speculation.
.png)
.svg)
.svg)
%201%20(1).svg)
.svg)
%20(3).webp)
.png)
.png){kind=spacer}
.png){kind=spacer}
.png){kind=spacer}
.png){kind=spacer}
.png){kind=spacer}
.png){kind=spacer}
.webp)
.webp)
.webp){kind=spacer}
.webp){kind=spacer}
.webp)
.webp)
.webp)
.webp){kind=spacer}
.webp)
.webp)
.webp)
.webp)
.webp)
.svg)
%20(1).svg)
